Seres Therapeutics, Inc. (MCRB) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 358K | 438K | 351K | 0 | 0 | 0 | 0 | 0 | 0 | 64K | 0 | 126.47M | -522K | 975K | 3.44M | 1.22M | 1.49M | 7.22M | 126.72M | 5.26M |
| Revenue Growth % | - | - | - | - | - | -100% | - | -100% | 100% | -93.44% | -100% | 10300.74% | -134.96% | -86.5% | -97.28% | -76.9% | -73.89% | -58.89% | 8843.19% | -12.94% |
| Cost of Goods Sold | 0 | -13.8M | 13.35M | 1.06M | 3.53M | 0 | 1.4M | 0 | 0 | 0 | 0 | 46.79M | 43.97M | 46.22M | 0 | 43.94M | 39.65M | 36.75M | 39.88M | 35.95M |
| COGS % of Revenue | - | -3151.83% | 3803.99% | - | - | - | - | - | - | - | - | 37% | -8423.18% | 4740.51% | - | 3613.08% | 2655.66% | 508.96% | 31.47% | 683.15% |
| Gross Profit | 0 | 14.24M | -13M | -1.06M | -3.53M | 0 | -1.4M | 0 | 0 | 64K | 0 | 79.68M | -44.49M | -45.24M | 3.44M | -42.72M | -38.16M | -29.53M | 86.84M | -30.69M |
| Gross Margin % | - | 3251.83% | -3703.99% | - | - | - | - | - | - | 100% | - | 63% | 8523.18% | -4640.51% | 100% | -3513.08% | -2555.66% | -408.96% | 68.53% | -583.15% |
| Gross Profit Growth % | 100% | - | -826% | - | - | -100% | - | -100% | 100% | 100.14% | -100% | 286.52% | -16.6% | -53.21% | -96.03% | -39.19% | -61.78% | -304.37% | 6028.65% | -607.71% |
| Operating Expenses | 21.27M | 33.62M | 9.48M | 23.82M | 23.71M | 28.84M | 29.17M | 28.87M | 34.44M | 39.59M | 44.59M | 30.16M | 26.08M | 23.06M | 62.55M | 20.61M | 17.59M | 19.9M | 18.44M | 17.45M |
| OpEx % of Revenue | 5939.94% | 7675.8% | 2699.72% | - | - | - | - | - | - | 61859.38% | - | 23.84% | -4995.59% | 2365.33% | 1816.23% | 1694.57% | 1178.5% | 275.6% | 14.55% | 331.58% |
| Selling, General & Admin | 8.07M | 7.54M | 9.48M | 10.25M | 11.89M | 12.46M | 12.71M | 13.06M | 14.94M | 17.23M | 19.43M | 28.05M | 22.47M | 22.4M | 18.38M | 20.34M | 18.57M | 20.51M | 19.56M | 17.45M |
| SG&A % of Revenue | 2254.19% | 1721.23% | 2699.72% | - | - | - | - | - | - | 26928.13% | - | 22.18% | -4304.6% | 2297.85% | 533.8% | 1672.29% | 1243.87% | 283.98% | 15.44% | 331.58% |
| Research & Development | 13.2M | 11.68M | 0 | 12.94M | 11.82M | 12.84M | 16.46M | 15.81M | 19.49M | 26.85M | 25.15M | 46.79M | 43.97M | 46.22M | 43.12M | 43.94M | 39.65M | 36.75M | 39.88M | 35.95M |
| R&D % of Revenue | 3685.75% | 2667.58% | - | - | - | - | - | - | - | 41946.88% | - | 37% | -8423.18% | 4740.51% | 1251.92% | 3613.08% | 2655.66% | 508.96% | 31.47% | 683.15% |
| Other Operating Expenses | 0 | 1000K | 0 | 630K | 0 | 1000K | 0 | 0 | 0 | -1000K | 0 | -1000K | -1000K | -1000K | 1000K | -1000K | -1000K | -1000K | -1000K | -1000K |
| Operating Income | -20.91M | -19.38M | -22.48M | -24.88M | -27.24M | -28.84M | -29.17M | -28.87M | -34.44M | -39.53M | -44.59M | 49.52M | -70.57M | -68.31M | -59.11M | -63.33M | -55.75M | -49.43M | 68.41M | -48.14M |
| Operating Margin % | -5839.94% | -4423.97% | -6403.7% | - | - | - | - | - | - | -61759.38% | - | 39.16% | 13518.77% | -7005.85% | -1716.23% | -5207.65% | -3734.16% | -684.56% | 53.98% | -914.73% |
| Operating Income Growth % | 23.24% | 32.8% | 22.94% | 13.82% | 20.91% | 27.05% | 34.58% | -158.3% | 51.2% | 42.13% | 24.57% | 178.21% | -26.58% | -38.18% | -186.4% | -31.54% | -57.82% | -176.19% | 328.06% | -134.32% |
| EBITDA | -20.91M | -17.24M | -21.42M | -23.82M | -26.16M | -27.75M | -27.77M | -27.45M | -32.88M | -37.89M | -42.9M | 51.05M | -69.17M | -66.68M | -57.36M | -61.64M | -54.18M | -47.88M | 69.9M | -46.72M |
| EBITDA Margin % | -5839.94% | -3936.53% | -6101.99% | - | - | - | - | - | - | -59209.38% | - | 40.37% | 13250.57% | -6838.97% | -1665.51% | -5069.08% | -3629% | -663.07% | 55.16% | -887.63% |
| EBITDA Growth % | 20.08% | 37.87% | 22.86% | 13.22% | 20.44% | 26.77% | 35.28% | -153.77% | 52.46% | 43.17% | 25.21% | 182.82% | -27.66% | -39.26% | -182.06% | -31.95% | -60.06% | -192.15% | 345.96% | -147.78% |
| D&A (Non-Cash Add-back) | 0 | 2.13M | 1.06M | 1.06M | 1.08M | 1.08M | 1.4M | 1.42M | 1.56M | 1.63M | 1.68M | 1.53M | 1.4M | 1.63M | 1.75M | 1.69M | 1.57M | 1.55M | 1.49M | 1.43M |
| EBIT | 0 | -19.38M | 8.2M | -19.86M | 32.68M | -15.64M | -51.03M | -26.2M | -32.28M | -37.22M | -41.02M | 49.52M | -70.57M | -68.31M | -58.27M | -63.33M | -55.75M | -49.43M | 68.41M | -48.14M |
| Net Interest Income | 0 | 445K | 618K | 546K | 618K | 437K | 652K | -2.22M | -3.02M | -2.06M | -1.44M | -1.46M | -916K | -466K | -862K | -1.11M | -528K | -253K | -154K | 97K |
| Interest Income | 325K | 445K | 618K | 546K | 618K | 437K | 652K | 1.23M | 1.65M | 1.97M | 2.57M | 1.73M | 1.03M | 1.41M | 865K | 395K | 384K | 485K | 590K | 829K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.45M | 4.66M | 4.03M | 4.01M | 3.19M | 1.95M | 1.88M | 1.73M | 1.5M | 912K | 738K | 744K | 732K |
| Other Income/Expense | 994K | 4.04M | 30.68M | 5.03M | 59.92M | 13.2M | -21.86M | 2.67M | 1.53M | -1.72M | 3.57M | -2.97M | -606K | -489K | -895K | -1.41M | -873K | -569K | -189K | -188K |
| Pretax Income | -19.91M | -15.34M | 8.2M | -19.86M | 32.68M | -15.64M | -51.03M | -26.2M | -32.9M | -41.25M | -41.02M | 46.55M | -71.17M | -68.8M | -60M | -64.73M | -56.62M | -50M | 68.22M | -48.33M |
| Pretax Margin % | -5562.29% | -3501.14% | 2337.32% | - | - | - | - | - | - | -64450% | - | 36.81% | 13634.87% | -7056% | -1742.22% | -5323.6% | -3792.63% | -692.44% | 53.83% | -918.3% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -19.91M | -15.34M | 8.2M | -19.86M | 32.68M | -15.64M | 88.78M | -32.87M | -40.13M | -41.25M | -47.85M | 46.55M | -71.17M | -68.8M | -60M | -64.73M | -56.62M | -50M | 68.22M | -48.33M |
| Net Margin % | -5562.29% | -3501.14% | 2337.32% | - | - | - | - | - | - | -64450% | - | 36.81% | 13634.87% | -7056% | -1742.22% | -5323.6% | -3792.63% | -692.44% | 53.83% | -918.3% |
| Net Income Growth % | -160.93% | 1.93% | -90.76% | 39.6% | 181.43% | 62.09% | 285.51% | -170.61% | 43.61% | 40.04% | 20.25% | 171.91% | -25.7% | -37.59% | -187.96% | -33.94% | -59.66% | -173.95% | 325.29% | -133.32% |
| Net Income (Continuing) | -19.91M | -15.34M | 8.2M | -19.86M | 32.68M | -15.64M | -51.03M | -26.2M | -32.9M | -41.25M | -41.02M | 46.55M | -71.17M | -68.8M | -60M | -64.73M | -56.62M | -50M | 68.22M | -48.33M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 1000K | -1000K | -1000K | 0 | -1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -2.08 | -1.76 | 0.94 | -2.27 | 3.75 | -1.81 | -7.59 | -4.34 | -5.49 | -6.38 | -7.46 | 7.17 | -11.31 | -10.99 | -9.79 | -14.03 | -12.29 | -10.88 | 14.37 | -10.55 |
| EPS Growth % | -155.47% | 2.76% | 112.38% | 47.7% | 168.31% | 71.64% | -1.74% | -160.53% | 51.46% | 41.92% | 23.83% | 151.09% | 7.96% | -0.96% | -168.16% | -33.08% | -58.56% | -172.67% | 298.19% | -86.6% |
| EPS (Basic) | -2.08 | -1.77 | 0.94 | -2.27 | 3.76 | -1.81 | -7.59 | -4.34 | -5.49 | -6.38 | -7.46 | 7.29 | -11.31 | -10.99 | -9.79 | -14.03 | -12.29 | -10.88 | 14.87 | -10.55 |
| Diluted Shares Outstanding | 9.58M | 8.87M | 8.77M | 8.74M | 8.71M | 8.65M | 7.63M | 7.58M | 7.31M | 6.46M | 6.41M | 6.49M | 6.29M | 6.26M | 6.13M | 4.61M | 4.61M | 4.59M | 4.75M | 4.58M |
| Basic Shares Outstanding | 9.58M | 8.86M | 8.76M | 8.74M | 8.7M | 8.65M | 7.63M | 7.58M | 7.31M | 6.46M | 6.41M | 6.39M | 6.29M | 6.26M | 6.13M | 4.61M | 4.61M | 4.59M | 4.59M | 4.58M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |